newsfilter
← Latest News
PR Newswire·

DarioHealth Reports Second Quarter 2026 Financial Results

Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discontinue certain pharmaceutical-related businessGross margin increased to 62%, compared to 57% in the first quarter of